105 related articles for article (PubMed ID: 21782781)
1. Identification of novel KCNQ4 openers by a high-throughput fluorescence-based thallium flux assay.
Li Q; Rottländer M; Xu M; Christoffersen CT; Frederiksen K; Wang MW; Jensen HS
Anal Biochem; 2011 Nov; 418(1):66-72. PubMed ID: 21782781
[TBL] [Abstract][Full Text] [Related]
2. A thallium-sensitive, fluorescence-based assay for detecting and characterizing potassium channel modulators in mammalian cells.
Weaver CD; Harden D; Dworetzky SI; Robertson B; Knox RJ
J Biomol Screen; 2004 Dec; 9(8):671-7. PubMed ID: 15634793
[TBL] [Abstract][Full Text] [Related]
3. Restoration of ion channel function in deafness-causing KCNQ4 mutants by synthetic channel openers.
Leitner MG; Feuer A; Ebers O; Schreiber DN; Halaszovich CR; Oliver D
Br J Pharmacol; 2012 Apr; 165(7):2244-59. PubMed ID: 21951272
[TBL] [Abstract][Full Text] [Related]
4. Development of a homogeneous calcium mobilization assay for high throughput screening of mas-related gene receptor agonists.
Zhang R; Yan PK; Zhou CH; Liao JY; Wang MW
Acta Pharmacol Sin; 2007 Jan; 28(1):125-31. PubMed ID: 17184592
[TBL] [Abstract][Full Text] [Related]
5. Validation of an atomic absorption rubidium ion efflux assay for KCNQ/M-channels using the ion Channel Reader 8000.
Wang K; McIlvain B; Tseng E; Kowal D; Jow F; Shen R; Zhang H; Shan QJ; He L; Chen D; Lu Q; Dunlop J
Assay Drug Dev Technol; 2004 Oct; 2(5):525-34. PubMed ID: 15671650
[TBL] [Abstract][Full Text] [Related]
6. Novel KCNQ2 channel activators discovered using fluorescence-based and automated patch-clamp-based high-throughput screening techniques.
Yue JF; Qiao GH; Liu N; Nan FJ; Gao ZB
Acta Pharmacol Sin; 2016 Jan; 37(1):105-10. PubMed ID: 26725738
[TBL] [Abstract][Full Text] [Related]
7. Comparison of human Ether-à-go-go related gene screening assays based on IonWorks Quattro and thallium flux.
Bridal TR; Margulis M; Wang X; Donio M; Sorota S
Assay Drug Dev Technol; 2010 Dec; 8(6):755-65. PubMed ID: 20658944
[TBL] [Abstract][Full Text] [Related]
8. High-throughput screening for Kv1.3 channel blockers using an improved FLIPR-based membrane-potential assay.
Liu K; Samuel M; Tillett J; Hennan JK; Mekonnen B; Soloveva V; Harrison RK; Paslay JW; Larocque J
J Biomol Screen; 2010 Feb; 15(2):185-95. PubMed ID: 20044579
[TBL] [Abstract][Full Text] [Related]
9. Aminoglycosides inhibit KCNQ4 channels in cochlear outer hair cells via depletion of phosphatidylinositol(4,5)bisphosphate.
Leitner MG; Halaszovich CR; Oliver D
Mol Pharmacol; 2011 Jan; 79(1):51-60. PubMed ID: 20935082
[TBL] [Abstract][Full Text] [Related]
10. Design, synthesis and biological activity of pyrazolo[1,5-a]pyrimidin-7(4H)-ones as novel Kv7/KCNQ potassium channel activators.
Qi J; Zhang F; Mi Y; Fu Y; Xu W; Zhang D; Wu Y; Du X; Jia Q; Wang K; Zhang H
Eur J Med Chem; 2011 Mar; 46(3):934-43. PubMed ID: 21296466
[TBL] [Abstract][Full Text] [Related]
11. Identification of non-peptidic neuromedin U receptor modulators by a robust homogeneous screening assay.
Meng T; Su HR; Binkert C; Fischli W; Zhou L; Shen JK; Wang MW
Acta Pharmacol Sin; 2008 Apr; 29(4):517-27. PubMed ID: 18358099
[TBL] [Abstract][Full Text] [Related]
12. Validation of a medium-throughput electrophysiological assay for KCNQ2/3 channel enhancers using IonWorks HT.
Jow F; Shen R; Chanda P; Tseng E; Zhang H; Kennedy J; Dunlop J; Bowlby MR
J Biomol Screen; 2007 Dec; 12(8):1059-67. PubMed ID: 18087070
[TBL] [Abstract][Full Text] [Related]
13. Identification of novel Kv1.3 blockers using a fluorescent cell-based ion channel assay.
Slack M; Kirchhoff C; Moller C; Winkler D; Netzer R
J Biomol Screen; 2006 Feb; 11(1):57-64. PubMed ID: 16314404
[TBL] [Abstract][Full Text] [Related]
14. Development and validation of a thallium flux-based functional assay for the sodium channel NaV1.7 and its utility for lead discovery and compound profiling.
Du Y; Days E; Romaine I; Abney KK; Kaufmann K; Sulikowski G; Stauffer S; Lindsley CW; Weaver CD
ACS Chem Neurosci; 2015 Jun; 6(6):871-8. PubMed ID: 25879403
[TBL] [Abstract][Full Text] [Related]
15. Comparative study of membrane potential-sensitive fluorescent probes and their use in ion channel screening assays.
Wolff C; Fuks B; Chatelain P
J Biomol Screen; 2003 Oct; 8(5):533-43. PubMed ID: 14567780
[TBL] [Abstract][Full Text] [Related]
16. Cell-based potassium ion channel screening using the FluxOR assay.
Beacham DW; Blackmer T; O' Grady M; Hanson GT
J Biomol Screen; 2010 Apr; 15(4):441-6. PubMed ID: 20208034
[TBL] [Abstract][Full Text] [Related]
17. Discovering potassium channel blockers from synthetic compound database by using structure-based virtual screening in conjunction with electrophysiological assay.
Liu H; Gao ZB; Yao Z; Zheng S; Li Y; Zhu W; Tan X; Luo X; Shen J; Chen K; Hu GY; Jiang H
J Med Chem; 2007 Jan; 50(1):83-93. PubMed ID: 17201412
[TBL] [Abstract][Full Text] [Related]
18. Thallium-sensitive fluorescent assay reveals loperamide as a new inhibitor of the potassium channel Kv10.1.
Loza-Huerta A; Milo E; Picones A; Hernández-Cruz A; Luis E
Pharmacol Rep; 2021 Dec; 73(6):1744-1753. PubMed ID: 34213738
[TBL] [Abstract][Full Text] [Related]
19. [High throughput screening method of potassium channel regulators].
Pan YP; Xu XH; Wang XL
Yao Xue Xue Bao; 2004 Feb; 39(2):85-8. PubMed ID: 15127611
[TBL] [Abstract][Full Text] [Related]
20. A cell-based Rb(+)-flux assay of the Kv1.3 potassium channel.
Gill S; Gill R; Wicks D; Liang D
Assay Drug Dev Technol; 2007 Jun; 5(3):373-80. PubMed ID: 17638537
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
